#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adenomatous polyposis coli Nephrotic syndrome Congenital absence of bile ducts Hairy cell leukaemia Liposarcoma recurrent Toxic epidermal necrolysis General anaesthesia Epileptic encephalopathy Short stature Spinal cord injury Splenic marginal zone lymphoma Bulbospinal muscular atrophy congenital Soft tissue necrosis Endocrine ophthalmopathy Bladder cancer More trials…

    Learn about Rare Diseases

    Lennox-Gastaut syndrome – Basic Information Focal segmental glomerulosclerosis – Basic Information Fabry’s disease – Diagnostics Marfan’s syndrome – Life with Disease Noonan syndrome – Trials in Disease Leiomyosarcoma recurrent Marginal zone lymphoma Pleural mesothelioma malignant Stevens-Johnson syndrome – Treatment Congenital nephrogenic diabetes insipidus – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GSKVX000000044501 Suxamethonium Chloride Lerodalcibep Capecitabine Eprosartan Mesilate Sodium Sulfate Anhydrous Sotatercept Mianserin Hydrochloride Gad20-209-Fsp-A2 Mecillinam Mesna Lutikizumab Buspirone Hydrochloride 68Ganota-Anti-Her2 Vhh1 DAPIGLUTIDE Citalopram Dostarlimab Enlicitide Chloride Pervi-Fus Tretinoin More therapies…

    Learn about Your Condition

    Deafness neurosensory Mechanical ventilation Anaemia of chronic disease Metastatic glioma Pituitary tumour benign Gastrointestinal disorder Pericarditis Gastrooesophageal cancer Radiation skin injury Prostate cancer recurrent Arthroscopy Herpes simplex meningitis Langerhans' cell histiocytosis Mucopolysaccharidosis II Cold urticaria More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • PET Imaging with [18F]AlF-FAPI-74 and Hyoscine Butylbromide in Patients Suspected of Endometriosis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Endometriosis
    Investigated Drugs:
    • Hyoscine Butylbromide
    • [Al[18F]F]Fapi-74
    Belgium

  • Phase Ib/II Study of LP-184 in Patients with Advanced or Metastatic Urothelial Carcinoma

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma
    Denmark

  • Preventing urinary tract infections in infants and children under 2 years with oral Escherichia coli strain Nissle 1917 probiotic: a randomized controlled trial

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Urinary tract infection
    Investigated Drugs:
    • Escherichia Coli Strain Nissle 1917
    Finland

  • Early switch to oral amoxicillin (drug combination) for adults with vertebral osteomyelitis: a randomised non‑inferiority trial

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Cefalexin
    • Flucloxacillin
    • Moxifloxacin
    Germany

  • A Phase 2a Study of Empasiprubart IV Monotherapy in Adults with AChR‑Ab Seropositive Generalized Myasthenia Gravis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Empasiprubart
    • Efgartigimod Alfa
    Belgium Germany Greece Italy The Netherlands Poland +1

  • Efficacy and Safety of E2086 in Adults with Narcolepsy: A Randomized, Double‑Blind, Placebo‑Controlled Trial

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Narcolepsy
    Belgium Germany Italy Spain
Previous Page
1 … 680 681 682 683 684 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!